Multiple sclerosis (MS) is the most frequently seen demyelinating disease, with a prevalence
that varies considerably, from high levels in North America and Europe (> 100/100,000 …

Data on the prevalence of multiple sclerosis (MS) in France are scarce. National and
regional updated estimates are needed to better plan health policies. In this nationwide …

Multiple sclerosis (MS) is a chronic and potentially highly disabling disorder with
considerable social impact and economic consequences. It is the major cause of non …

Multiple sclerosis (MS) is among the most intensively studied neurologic diseases from an
epidemiologic point of view. Its inhomogeneous geographic occurrence has suggested that …

Multiple sclerosis (MS) is a progressive demyelinating and degenerative disease of the CNS
with symptoms dependent on the type of the disease and the site of lesions. During the …

This study aims to describe the prevalence and incidence rates of multiple sclerosis (MS) in
Lorraine, France, and its secular trend from 1990 to 2002. Cases were sourced from the …

Multiple sclerosis (MS) progression to mortality may not be solely determined by the
underlying autoimmune process. We conducted a study in a large cohort of MS patients with …

The epidemiology of multiple sclerosis (MS) has been thoroughly studied in developed
countries, particularly in areas traditionally known for their high prevalence. However, there …

Multiple sclerosis (MS) is the commonest non‐traumatic disabling disease to affect young
adults. The incidence of MS is increasing worldwide, together with the socioeconomic …

France is located in an area with a medium to high prevalence of multiple sclerosis, where
its epidemiology is not well known. We estimated the national and regional prevalence of …